Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12258)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2019 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhangdi HJ, Su SB, Wang F, Liang ZY, Yan YD, Qin SY, Jiang HX. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol 2019; 25(33): 4835-4849 [PMID: 31543677 DOI: 10.3748/wjg.v25.i33.4835] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i33/4835.htm |
| Number | Citing Articles |
| 1 |
Daphne Pinheiro, Isabelle Dias, Thiago Freire, Alessandra Alves Thole, Ana Carolina Stumbo, Erika Afonso Costa Cortez, Lais de Carvalho, Simone Nunes de Carvalho. Effects of mesenchymal stem cells conditioned medium treatment in mice with cholestatic liver fibrosis. Life Sciences 2021; 281: 119768 doi: 10.1016/j.lfs.2021.119768
|
| 2 |
Indu Rajapaksha. Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches. Livers 2022; 2(4): 372 doi: 10.3390/livers2040028
|
| 3 |
Asrin Ahmadi, Hossein Niknahad, Huifeng Li, Ali Mobasheri, Ram Kumar Manthari, Negar Azarpira, Khadijeh Mousavi, Bahman Khalvati, Yangfei Zhao, Jianyu Sun, Yuqi Zong, Mohammad Mehdi Ommati, Reza Heidari. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity. Toxicology Letters 2021; 349: 12 doi: 10.1016/j.toxlet.2021.05.012
|
| 4 |
Zilin Wang, Ya Zhang, Yinghui Wang, Qiuju Mou, Tingting Ren, Lili Zhu. Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF‐κB pathway. Journal of Biochemical and Molecular Toxicology 2023; 37(7) doi: 10.1002/jbt.23338
|
| 5 |
Dalia Kamal Mostafa, Maha M. Eissa, Doaa A. Ghareeb, Shaymaa Abdulmalek, Wafaa A. Hewedy. Resveratrol protects against Schistosoma mansoni-induced liver fibrosis by targeting the Sirt-1/NF-κB axis. Inflammopharmacology 2024; 32(1): 763 doi: 10.1007/s10787-023-01382-y
|
| 6 |
Kun Li, Jinfa Zheng, Han Liu, Qing Gao, Mengmeng Yang, Jiarong Tang, Hui Wang, Sheng Li, Yingbiao Sun, Xuhong Chang. Whole-transcriptome sequencing revealed differentially expressed mRNAs and non-coding RNAs played crucial roles in NiONPs-induced liver fibrosis. Ecotoxicology and Environmental Safety 2022; 248: 114308 doi: 10.1016/j.ecoenv.2022.114308
|
| 7 |
Yijing Ren, Siyue Li, Zixuan Song, Qiuping Luo, Yingying Zhang, Hao Wang. The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases. Nutrients 2022; 14(11): 2303 doi: 10.3390/nu14112303
|
| 8 |
Francesco Suriano, Sara Vieira-Silva, Gwen Falony, Alice de Wouters d'Oplinter, Paola Paone, Nathalie M. Delzenne, Amandine Everard, Jeroen Raes, Matthias Van Hul, Patrice D. Cani. Fat and not sugar as the determining factor for gut microbiota changes, obesity, and related metabolic disorders in mice. American Journal of Physiology-Endocrinology and Metabolism 2023; 324(1): E85 doi: 10.1152/ajpendo.00141.2022
|
| 9 |
Jianping Sheng, Baohang Zhang, Yongfeng Chen, Fuxiang Yu. Capsaicin attenuates liver fibrosis by targeting Notch signaling to inhibit TNF-α secretion from M1 macrophages. Immunopharmacology and Immunotoxicology 2020; 42(6): 556 doi: 10.1080/08923973.2020.1811308
|
| 10 |
Tao Li, GuangYue Su, YuQing Zhao. Anti‐hepatic fibrosis effects of AD‐2 affecting the Raf–MEK signaling pathway and inflammatory factors in thioacetamide‐induced liver injury. Journal of Food Science 2021; 86(6): 2753 doi: 10.1111/1750-3841.15731
|
| 11 |
Anggun Lestary Husein, Isabella Kurnia Liem. Pathomechanism of Liver Fibrosis and Mesenchymal Stem Cells in its Resolution Process. Open Access Macedonian Journal of Medical Sciences 2023; 11(F): 86 doi: 10.3889/oamjms.2023.11342
|
| 12 |
Jianxia Wen, Dan Wang, Jian Wang, Ruilin Wang, Shizhang Wei, Yanling Zhao, Chih-Yuan Ko. Astragali Radix Contributes to the Inhibition of Liver Fibrosis via High-Mobility Group Box 1-Mediated Inflammatory Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5574010
|
| 13 |
Sujie Liu, Juan Wu, Pingping Chen, Shadi A. D. Mohammed, Jingbo Zhang, Shumin Liu, Syed Sameer Aga. TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4949148
|
| 14 |
Hui Li. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma. Expert Review of Gastroenterology & Hepatology 2021; 15(3): 217 doi: 10.1080/17474124.2021.1842732
|
| 15 |
Chang Fan, Fu Rong Wu, Jia Fu Zhang, Hui Jiang, Silvia Wein. A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/4780383
|
| 16 |
Luiza M. Karzakova, Antonina L. Ivanova, Sergei I. Kudryashov, Evgeniya V. Sokolova, Tatyana S. Lutkova. IMMUNE MECHANISMS FOR THE DEVELOPMENT OF HEPATORENAL SYNDROME IN LIVER CIRRHOSIS. Acta medica Eurasica 2020; (3): 7 doi: 10.47026/2413-4864-2020-3-7-19
|
| 17 |
Baharan Fekry, Aleix Ribas‐Latre, Rachel Van Drunen, Rafael Bravo Santos, Samay Shivshankar, Yulin Dai, Zhongming Zhao, Seung‐hee Yoo, Zheng Chen, Kai Sun, Frances M. Sladek, Mamoun Younes, Kristin Eckel‐Mahan. Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis. The FASEB Journal 2022; 36(9) doi: 10.1096/fj.202101398R
|
| 18 |
Simona-Rebeca Ignat, Sorina Dinescu, Anca Hermenean, Marieta Costache. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development. Cells 2020; 9(2): 461 doi: 10.3390/cells9020461
|
| 19 |
Ya Yang, Yalei Zhao, Lingjian Zhang, Fen Zhang, Lanjuan Li. The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.655268
|
| 20 |
Nazli Khodayari, Regina Oshins, L. Shannon Holliday, Virginia Clark, Qiang Xiao, George Marek, Borna Mehrad, Mark Brantly. Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo. Cell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00648-0
|
| 21 |
Farnaz Sani, Mina Soufi Zomorrod, Negar Azarpira, Masoud Soleimani, Hirotaka Suga. The Effect of Mesenchymal Stem Cell-Derived Exosomes and miR17-5p Inhibitor on Multicellular Liver Fibrosis Microtissues. Stem Cells International 2023; 2023: 1 doi: 10.1155/2023/8836452
|
| 22 |
Silvano Fasolato, Emanuela Bonaiuto, Monica Rossetto, Paola Vanzani, Fabio Ceccato, Fabio Vittadello, Lucio Zennaro, Adelio Rigo, Enzo Mammano, Paolo Angeli, Patrizia Pontisso, Maria Luisa Di Paolo. Serum Vascular Adhesion Protein-1 and Endothelial Dysfunction in Hepatic Cirrhosis: Searching for New Prognostic Markers. International Journal of Molecular Sciences 2024; 25(13): 7309 doi: 10.3390/ijms25137309
|
| 23 |
Qiuyun Yi, Jinxian Yang, Ying Wu, Ying Wang, Qiqi Cao, Wen Wen. Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1204524
|
| 24 |
Pragyan Acharya, Komal Chouhan, Sabine Weiskirchen, Ralf Weiskirchen. Cellular Mechanisms of Liver Fibrosis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.671640
|
| 25 |
Huanyu Xiang, Jing Xiao, Zilin Sun, Zongyi Liu, Junhao Zhang, Hongyan Xiang, Hong Ren, Peng Hu, Mingli Peng. The anti-fibrotic efficacy of adelmidrol depends on hepatic PPARγ levels. Biomedicine & Pharmacotherapy 2023; 165: 115051 doi: 10.1016/j.biopha.2023.115051
|
| 26 |
Bingjian Wen, Chengcheng Zhang, Jingwen Zhou, Zhengyan Zhang, Qishi Che, Hua Cao, Yan Bai, Jiao Guo, Zhengquan Su. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways. Pharmacology & Therapeutics 2021; 222: 107752 doi: 10.1016/j.pharmthera.2020.107752
|
| 27 |
Haili Wang, Jinying Che, Kai Cui, Wenyue Zhuang, He Li, Jinghui Sun, Jianguang Chen, Chunmei Wang. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo. Phytomedicine 2021; 88: 153609 doi: 10.1016/j.phymed.2021.153609
|
| 28 |
Mustafa Ghanim, Johnny Amer, Ahmad Salhab, Nidal Jaradat. Ecballium elaterium improved stimulatory effects of tissue-resident NK cells and ameliorated liver fibrosis in a thioacetamide mice model. Biomedicine & Pharmacotherapy 2022; 150: 112942 doi: 10.1016/j.biopha.2022.112942
|
| 29 |
Sergio C. Oliveira, M. Victoria Delpino, Guillermo Hernán Giambartolomei, Jorge Quarleri, Gary Splitter. Editorial: Advances in Liver Inflammation and Fibrosis Due to Infectious Diseases. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01760
|
| 30 |
Yu-long Bao, Li Wang, Hai-ting Pan, Tai-ran Zhang, Ya-hong Chen, Shan-jing Xu, Xin-li Mao, Shao-wei Li. Animal and Organoid Models of Liver Fibrosis. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.666138
|
| 31 |
The anti-liver fibrosis effect of Tibetan medicine (Qiwei Tiexie capsule) is related to the inhibition of NLRP3 inflammasome activation in vivo and in vitro. Journal of Ethnopharmacology 2024; 319: 117283 doi: 10.1016/j.jep.2023.117283
|
| 32 |
Usman Sabir, Hong‐mei Gu, Da‐Wei Zhang. Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis. Phytotherapy Research 2023; 37(11): 4932 doi: 10.1002/ptr.7959
|
| 33 |
Yimin Sun, Bingyan Liu, Jianping Xie, Xuefeng Jiang, Baolai Xiao, Xiaomiao Hu, Jinjian Xiang. Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signaling. Molecular Medicine Reports 2022; 25(5) doi: 10.3892/mmr.2022.12697
|
| 34 |
Liqun Li, Jing Yan, Qian Liu, Laian Ge, Yifeng Pan, Bingjie Han, Chunmei Wang, Xiaomei Tang, Lijian Liu, Sheng Xie. Association of MCP-4, NRTN, and PD-L1 with the risk of hepatic fibrosis: A Mendelian randomization study. Medicine 2024; 103(36): e39655 doi: 10.1097/MD.0000000000039655
|
| 35 |
Mishghan Zehra, James C. Curry, Sneha S. Pillai, Hari Vishal Lakhani, Cory E. Edwards, Komal Sodhi. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis. International Journal of Molecular Sciences 2020; 21(13): 4737 doi: 10.3390/ijms21134737
|
| 36 |
Zuleyha Erisgin, Hasan Serdar Mutlu, Yavuz Tekelioglu, Engin Deveci, Ugur Seker. Hepatotoxic effects of melamine exposure from the weaning period in rats: a flow cytometric, electron microscopic, and histopathologic study. Toxicology Research 2021; 10(3): 418 doi: 10.1093/toxres/tfab022
|
| 37 |
Mengting Zhou, Naihua Hu, Meichen Liu, Ying Deng, Linfeng He, Chaocheng Guo, Xingtao Zhao, Yunxia Li. A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5462063
|
| 38 |
Xingtao Zhao, Jing Wang, Ying Deng, Li Liao, Mengting Zhou, Cheng Peng, Yunxia Li. Quercetin as a protective agent for liver diseases: A comprehensive descriptive review of the molecular mechanism. Phytotherapy Research 2021; 35(9): 4727 doi: 10.1002/ptr.7104
|
| 39 |
Rui Qin, Qian Zhao, Bo Han, Hong-Ping Zhu, Cheng Peng, Gu Zhan, Wei Huang. Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.845892
|
| 40 |
Hui Yang, Juan Wang, Zhen‐Guo Liu. Multi‐faceted role of pyroptosis mediated by inflammasome in liver fibrosis. Journal of Cellular and Molecular Medicine 2022; 26(10): 2757 doi: 10.1111/jcmm.17277
|
| 41 |
Xiao-yan He, Xiao-jiao Xiong, Mei-jun Liu, Jing-tao Liang, Fu-you Liu, Jing-yi Xiao, Li-juan Wu. Dahuang Zhechong Pill Alleviates Liver Fibrosis Progression by Regulating p38 MAPK/NF-κ B/TGF-β1 Pathway. Chinese Journal of Integrative Medicine 2024; 30(12): 1113 doi: 10.1007/s11655-024-3801-x
|
| 42 |
Ibrahim A Ahmed, Miran A Jaffa, Mayssam Moussa, Duaa Hatem, Ghewa A El-Achkar, Rola Al Sayegh, Mia Karam, Eva Hamade, Aida Habib, Ayad A Jaffa. Plasma Kallikrein as a Modulator of Liver Injury/Remodeling. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.715111
|
| 43 |
|
| 44 |
Erika Ramos-Tovar, Pablo Muriel. Antioxidants. Vitamins and Hormones 2023; 121: 271 doi: 10.1016/bs.vh.2022.09.006
|
| 45 |
Qilin Meng, Lin Luo, Minghua Lei, Zhiqi Chen, Yuanmeng Sun, Xue Chen, Zhaodong Zhai, Yibo Zhang, Jieqiong Cao, Zijian Su, Fu Li, Jingsheng Li, An Hong, Xiaojia Chen. Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis. Pharmaceuticals 2023; 16(4): 548 doi: 10.3390/ph16040548
|